NVCT:NASDAQ, Nuvectis Pharma, Inc.

NVCT stock overview

Nuvectis Pharma, Inc. (NVCT:NASDAQ) closed at $18.76 on October 15, 2026, up 4.22% on the day. The stock trades 35.9% below its 52-week high of $29.28 and 238.0% above its 52-week low of $5.55. Over the past year, it gained 195.6%. Nuvectis Pharma, Inc. is part of the Health Care sector.

Key figures

Price
$18.76
Day change
+4.22%
Volume
6,223
Average volume
215,204
Market cap
612M+
52-week range
$5.55 – $29.28
50-day average
$21.62
200-day average
$13.95

Performance

5D 1M 3M 6M 1Y
-8.58% -17.88% -5.96% +116.09% +195.57%

Price action over the past year

In 252 trading sessions since October 14, 2025, NVCT closed higher on 137 days (54%). Its best day was June 24, 2026 (+39.49%) and its worst was June 30, 2026 (-35.54%). The stock moved 10% or more in a single session 10 times.

Recent signals

NVCT news

About Nuvectis Pharma, Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its pipeline products include NXP800, NXP900.

Find more stocks like NVCT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.